SEC Form 4 · accession 0001179110-19-001519
Editas Medicine, Inc. · EDIT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Scadden
Director
Period of report
Feb 5, 2019
Accepted (ET)
Feb 7, 2019 · 4:41 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001650664
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $21.14 | Feb 5, 2019 | A | 23,076 | A | — | Feb 4, 2029 | Common Stock | 23,076 | 23,076 | D |
Explanation of responses
- F1This option was granted on February 5, 2019 and is scheduled to vest over three years in equal yearly installments of one-third of the shares beginning on February 5, 2020 through February 5, 2022.